Pharvaris (PHVS) Operating Expenses (2020 - 2026)

Pharvaris (PHVS) has 7 years of Operating Expenses data on file, last reported at -$51.8 million in Q1 2026.

• Quarterly Operating Expenses fell 16.8% year-over-year to -$51.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$199.3 million (down 16.41% YoY) and the FY2025 annual result came in at -$191.9 million, down 21.68% from the prior year.
• Operating Expenses rose to -$51.8 million in Q1 2026, from -$55.4 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $179.3 million in Q4 2023 to a low of -$55.4 million in Q4 2025.
• A 5-year average of -$12.5 million and a median of -$30.8 million in 2024 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2023 — Operating Expenses advanced 17.27% — and 2024, when it slumped 126.87%.
• Tracing PHVS's Operating Expenses over 5 years: stood at $152.9 million in 2022, then grew by 17.27% to $179.3 million in 2023, then tumbled by 126.87% to -$48.2 million in 2024, then decreased by 14.99% to -$55.4 million in 2025, then climbed by 6.45% to -$51.8 million in 2026.
• The last three Operating Expenses figures came in at -$51.8 million (Q1 2026), -$55.4 million (Q4 2025), and -$46.4 million (Q3 2025), per Business Quant data.